1. Home
  2. BGS vs VRXA Comparison

BGS vs VRXA Comparison

Compare BGS & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGS

B&G Foods Inc.

HOLD

Current Price

$3.44

Market Cap

297.1M

ML Signal

HOLD

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.98

Market Cap

263.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGS
VRXA
Founded
1996
N/A
Country
United States
Switzerland
Employees
86
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.1M
263.0M
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
BGS
VRXA
Price
$3.44
$1.98
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$4.90
N/A
AVG Volume (30 Days)
2.3M
154.8K
Earning Date
05-12-2026
N/A
Dividend Yield
14.34%
N/A
EPS Growth
83.02
N/A
EPS
N/A
N/A
Revenue
$1,828,687,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.32
$1.70
52 Week High
$6.38
$4.50

Technical Indicators

Market Signals
Indicator
BGS
VRXA
Relative Strength Index (RSI) 42.08 42.65
Support Level $3.35 $1.74
Resistance Level $3.75 $2.00
Average True Range (ATR) 0.13 0.12
MACD 0.00 0.05
Stochastic Oscillator 24.36 86.00

Price Performance

Historical Comparison
BGS
VRXA

About BGS B&G Foods Inc.

B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: